Hyderabad: In the wake of a cyber attack, the Indian pharma giant, Dr. Reddy’s Laboratories, has isolated all data center services across the globe to take required preventive actions, it said in a statement on 22 October.
Commenting on this development, Mukesh Rathi, the CIO of Dr. Reddy’s Laboratories, said, “We are anticipating all services to be up within 24 hours. We do not foresee any major impact on our operations due to this incident.”
According to sources, the attack was detected in the wee hours of Thursday, following which a high alert had been sounded at all data centers across the globe. While major operations have been temporarily hit due to the attack, works are on to restore the operations on a war footing.
The attack comes just a few days after the Hyderabad-based Dr. Reddy’s Laboratories Ltd., which is in the forefront for making a COVID-19 vaccine along with Russian Direct Investment Fund, Russia's sovereign wealth fund, had received approval from the Drug Control General of India to conduct an adaptive phase 2/3 human clinical trial for Sputnik V vaccine in India.
This will be a multi-center and randomised controlled study, which will include safety and immunogenicity study, said Dr Reddy’s in a release last week. In September, Dr. Reddy’s and Russian Direct Investment Fund had entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.